Dare Bioscience DARE
NASDAQ DARE
$0.68 -0.01 (-1.26%)
As of: Oct 21, 2026 · 3:49 PM EDT

Dare Bioscience (DARE) Short term Debt (2013 - 2025)

Updated

Dare Bioscience (DARE) reported Short term Debt of $10,542 for Q3 2025, down 94.4% from the prior quarter.

Analysis

Dare Bioscience (DARE) Short term Debt (2013 - 2025) Analysis & Trends

At the end of FY2024, Dare Bioscience posted Short term Debt of $4,054.

  • Five-year quarterly Short term Debt spans a low of $4,054 in Q4 2024 and a high of $187,966 in Q2 2025.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $187,966 (Q2 2025), $91,907 (Q1 2025) and $4,054 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Dare Bioscience 10.13 Mn -55.33 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 10,542.00
Jun 30, 2025 187,966.00
Mar 31, 2025 91,907.00
Dec 31, 2024 4,054.00
Dec 31, 2016 8.38 Mn
Sep 30, 2016 8.19 Mn
Jun 30, 2016 8.02 Mn
Mar 31, 2016 7.83 Mn
Dec 31, 2015 7.65 Mn
Sep 30, 2015 4.03 Mn
Jun 30, 2015 2.65 Mn
Mar 31, 2015 836,000.00
Dec 31, 2014 3.12 Mn
Sep 30, 2014 3.35 Mn
Jun 30, 2014 3.27 Mn
Mar 31, 2014 3.20 Mn
Dec 31, 2013 3.13 Mn
API Access

Dare Bioscience Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=DARE&period=max&api_key=YOUR_API_KEY